HEPATOCELLULAR TRANSPLANTATION AND TARGETING GENETIC MARKERS TO HEPATIC CELLS 
child because of this experimental procedure. Your medical record will remain 
confidential, and your child's name will not be identified in any scientific reports of 
this procedure. The hospital staff will work with you to protect your public anonymity 
and privacy. We recommend that you do not talk to the press or community without the 
assistance of the public relations office at the Texas Children's Hospital or your 
physicians . 
<par 13> You will not be asked to pay for the costs for the liver cell injection, 
subsequent studies to determine whether this therapy was successful, or tests on the 
safety of the marker gene. You will continue to be charged for tests and treatments 
that are clinically required because of the your child's ongoing liver disease. 
<par 14> We encourage you to ask questions about the details of this procedure of any 
of the physicians who have cared for your child, the researchers who have proposed this 
study, hospital staff, family members, clergy, or any other individuals who might offer 
you support or advice. Your physicians and the investigators can be reached at the 
following numbers; 
Fred Ledley, M.D. 798-6423 
George Ferry. M.D. 798-2940 
Hartwell Whisennand, M.D. 790-2180 
Savio Woo, Ph.D. 798-6080 
In the event of injury resulting from this research, Baylor College of Medicine 
and/or Texas Children's Hospital is not able to offer financial compensation nor to 
absorb the costs of medical treatment. However, necessary facilities, emergency 
treatment, and professional services will be available to research subjects, ^ust as 
they are to the community generally . 
My signature below acknowledges my voluntary participation in this research project 
but in no way releases the investigators from their professional and ethical 
responsibility. 
Parent or Guardian Date 
Witness Date 
Investigator 
Date 
Recombinant DNA Research, Volume 14 
[829] 
